DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: Usefulness and limitations

Human Genetics

Volumn 108, Issue 5, 2001, Pages 376-384

  Klein, B ^a   Weirich, G ^a   Brauch, H ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ACCURACY; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEVICE; DISEASE CARRIER; DNA SEQUENCE; EXON; FAMILIAL INCIDENCE; GENE MUTATION; GENETIC SCREENING; GERM LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; EXONS; FRAMESHIFT MUTATION; GC RICH SEQUENCE; GENES, TUMOR SUPPRESSOR; GENETIC SCREENING; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; LIGASES; MUTATION, MISSENSE; NUCLEIC ACID DENATURATION; PROTEINS; REPRODUCIBILITY OF RESULTS; RNA SPLICE SITES; SENSITIVITY AND SPECIFICITY; TEMPERATURE; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0035007102     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390100500     Document Type: Article

References (35)

1. A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers
2. Software and database for the analysis of mutations in the VHL gene
3. UMD (Universal mutation database): A generic software to build and analyze locus-specific databases
4. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: Evidence for a founder effect
5. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma
6. VHL alterations in human clear cell renal cell carcinoma: Association with advanced tumor stage and a novel hot spot mutation
7. Genotype-phenotype correlation in von Hippel-Lindau disease: Identification of a mutation associated with VHL type 2A
8. Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2
9. Current methods of mutation detection
10. A comparison of fluorescent SSCP and denaturing HPLC for high-throughput mutation scanning
11. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma
12. Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe
13. Von Hippel-Lindau disease. Clinical review and molecular genetics
14. Mutations of the VHL tumour suppressor gene in renal carcinoma
15. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC
16. Identification of specific BRCA1 and BRCA2 variants by DHPLC
17. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
18. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis
19. Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis
20. Identification of the von Hippel-Lindau disease tumor suppressor gene
21. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease
22. Basic criteria for clinical diagnosis and genetic counselling in von Hippel-Lindau syndrome
23. Von Hippel-Lindau syndrome
24. Signature-based analysis of MET proto-oncogene mutations using DHPLC
25. DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC)
26. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms
27. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization
28. Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene
29. Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): Comparison with DNA-SSCP
30. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
31. BRCA1-related breast cancer in Austrian breast and ovarian cancer families: Specific BRCA1 mutations and pathological characteristics
32. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations
33. Global sequence diversity of BRCA2: Analysis of 71 breast cancer families and 95 control individuals of worldwide populations
34. Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan